Entrepreneurial Potentials of COVID-19 Vaccination
Ernest Jebolise Chukwuka, Amahi U. Fidelis
International Journal of TROPICAL DISEASE & Health · pp. 37–52 · Published 29 Oct 2021
10.9734/ijtdh/2021/v42i1530520Abstract
The study investigated the entrepreneurial potentials of COVID-19 vaccination. The objective of the study is to identify entrepreneurial potentials in COVID-19 vaccination, to determine the business viability of COVID-19 vaccine production and to identify how an entrepreneur can contribute to covid-19 vaccination. A descriptive survey research design was adopted for the study. The sample of the study was achieved using random sampling technique. The sample for this study was 69 respondents. These respondents were selected sixty nine (69) employees of health Centres and hospitals dispensing COVID-19 vaccines in Nigeria. The instrument used to collect data was the questionnaire. The data collected were analyzed using simple percentage, mean, standard and chi square. The overall finding of the study are that there is entrepreneurial potential in covid-19 vaccination, sales of vaccine, production of vaccine and distribution of vaccine are the entrepreneurial potentials in COVID-19 vaccination; the study also revealed that there is significant and positive relationship between Covid-19 vaccine production and profitability and It was also discovered that entrepreneurial innovation made Covid-19 vaccines possible and a viable business model. High demand of COVID-19 vaccine, global acceptance of the COVID-19 vaccine, effectiveness of the vaccine has made COVID-19 vaccine production a viable business. Base on the findings of the study, the following recommendations were made among others that government officials should support a more productive interaction and collaboration between them and pharmaceutical firms with a focus on capacity building for entrepreneurship development.
Cited by 1
Chukwuka, E. J., Iyamah, C. Y. · Journal of Advanced Research and Multidisciplinary Studies · 2024
Related research
- COVID 19 Disease Caused by Coronavirus 2 (SARS-CoV-2) (Severe Acute Respiratory Syndrome) — shares topic coverage
- Assessment of Anxiety in Healthcare Providers Working in ICU during COVID-19 Pandemics — shares topic coverage
- Azithromycin and Hydroxychloroquine Accelerate Recovery of Outpatients with Mild/Moderate COVID-19 — shares topic coverage
- Elevated Levels of Lactate Dehydrogenase Predicts Poor Outcomes for Patients with COVID-19: A Review — shares topic coverage
- Addressing the Challenges of Containing Covid-19 Spread in a Rural, Poor Area in India: A Case Study — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
1
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.